Skip to content

Application of high flow oxygen therapy combined with sterile endotracheal intubation in hysteroscopic surgery under intravenous anesthesia in obese patients

Application of high flow oxygen therapy combined with sterile endotracheal intubation in hysteroscopic surgery under intravenous anesthesia in obese patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105937
Enrollment
Unknown
Registered
2025-07-15
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia

Interventions

Experimental Group :High flow oxygen inhalation combined with sterile tracheal intubation

Sponsors

The First People's Hospital of Neijiang City
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 Age >= 18 years old; 2 ASA classification I-II; 3 Voluntarily accept this study.

Exclusion criteria

Exclusion criteria: 1 History of respiratory infections in the past 2 weeks; 2 History of asthma; 3 History of nasal congestion or acute rhinitis, pharyngitis or tonsillitis; 4 Emergency patients with full stomach or high risk of aspiration due to reflux; 5 Any illness that makes it difficult to cooperate; 6 Individuals allergic to relevant anesthetic drugs; 7 Individuals with SpO2 = 90% without oxygen inhalation; 8 Severe coagulation dysfunction, bleeding tendency, or during anticoagulant therapy; 9 Nasal mass or hemangioma; 0 Severe maxillary trauma or skull base fracture.

Design outcomes

Primary

MeasureTime frame
Incidence of hypoxemia;Proportion of additional airway interventions;

Secondary

MeasureTime frame
Low oxygen duration;Low oxygen level;

Countries

China

Contacts

Public ContactSongChao

The First People's Hospital of Neijiang City

2248237189@qq.com+86 183 8306 5550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026